Page last updated: 2024-08-16

ribavirin and Stroke

ribavirin has been researched along with Stroke in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abou-Samra, AB; Butt, AA; Freiberg, MS; Shaikh, OS; Shuaib, A; Yan, P1
Ho, HJ; Hsiao, NW; Hsu, YC; Huang, YT; Kao, YH; Lin, JT; Liu, YY; Wu, CY; Wu, MS1
Ho, HJ; Hsu, YC; Huang, YT; Lin, JT; Wang, HH; Wu, CY; Wu, MS1

Trials

1 trial(s) available for ribavirin and Stroke

ArticleYear
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

    Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome

2014

Other Studies

2 other study(ies) available for ribavirin and Stroke

ArticleYear
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.
    Gastroenterology, 2019, Volume: 156, Issue:4

    Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antiviral Agents; Cardiovascular Diseases; Coronary Artery Bypass; Drug Therapy, Combination; Female; Heart Failure; Hepatitis C, Chronic; Humans; Incidence; Interferon Type I; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Protective Factors; Ribavirin; Stroke; Sustained Virologic Response

2019
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
    Gut, 2015, Volume: 64, Issue:3

    Topics: Acute Coronary Syndrome; Adult; Antiviral Agents; Autoimmune Diseases; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Stroke; Treatment Outcome

2015